Segui
Genevieve M. Boland
Genevieve M. Boland
Massachusetts General Hospital
Email verificata su mgh.harvard.edu - Home page
Titolo
Citata da
Citata da
Anno
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
26302015
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
18052020
Defining T cell states associated with response to checkpoint immunotherapy in melanoma
M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ...
Cell 175 (4), 998-1013. e20, 2018
13412018
Adult mesenchymal stem cells and cell-based tissue engineering
RS Tuan, G Boland, R Tuli
Arthritis Res Ther 5, 1-14, 2002
12772002
A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ...
Cell 175 (4), 984-997. e24, 2018
9972018
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ...
Nature communications 8 (1), 1136, 2017
7982017
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells
GM Boland, G Perkins, DJ Hall, RS Tuan
Journal of cellular biochemistry 93 (6), 1210-1230, 2004
7132004
CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation
J Deng, ES Wang, RW Jenkins, S Li, R Dries, K Yates, S Chhabra, ...
Cancer discovery 8 (2), 216-233, 2018
5742018
Toward minimal residual disease-directed therapy in melanoma
F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ...
Cell 174 (4), 843-855. e19, 2018
5652018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
N Auslander, G Zhang, JS Lee, DT Frederick, B Miao, T Moll, T Tian, ...
Nature medicine 24 (10), 1545-1549, 2018
5562018
Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy
MT Chow, AJ Ozga, RL Servis, DT Frederick, JA Lo, DE Fisher, ...
Immunity 50 (6), 1498-1512. e5, 2019
4572019
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ...
Cancer discovery 8 (2), 196-215, 2018
4272018
Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics
LS Ludwig, CA Lareau, JC Ulirsch, E Christian, C Muus, LH Li, K Pelka, ...
Cell 176 (6), 1325-1339. e22, 2019
3882019
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ...
Cell 181 (2), 236-249, 2020
3702020
The human and mouse enteric nervous system at single-cell resolution
E Drokhlyansky, CS Smillie, N Van Wittenberghe, M Ericsson, GK Griffin, ...
Cell 182 (6), 1606-1622. e23, 2020
3262020
Formation and prevention of postoperative abdominal adhesions
GM Boland, RJ Weigel
Journal of Surgical Research 132 (1), 3-12, 2006
3082006
Molecular pathways of colon inflammation induced by cancer immunotherapy
AM Luoma, S Suo, HL Williams, T Sharova, K Sullivan, M Manos, ...
Cell 182 (3), 655-671. e22, 2020
2872020
Spatially organized multicellular immune hubs in human colorectal cancer
K Pelka, M Hofree, JH Chen, S Sarkizova, JD Pirl, V Jorgji, A Bejnood, ...
Cell 184 (18), 4734-4752. e20, 2021
2852021
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
G Oliveira, K Stromhaug, S Klaeger, T Kula, DT Frederick, PM Le, ...
Nature 596 (7870), 119-125, 2021
2762021
Granzyme B PET imaging as a predictive biomarker of immunotherapy response
BM Larimer, E Wehrenberg-Klee, F Dubois, A Mehta, T Kalomeris, ...
Cancer research 77 (9), 2318-2327, 2017
2642017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20